Small Volume Simethicone Before Gastroscopy: Any Benefit?

NCT ID: NCT02555228

Last Updated: 2016-03-15

Study Results

Results available

Outcome measurements, participant flow, baseline characteristics, and adverse events have been published for this study.

View full results

Basic Information

Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.

Recruitment Status

COMPLETED

Clinical Phase

PHASE2/PHASE3

Total Enrollment

54 participants

Study Classification

INTERVENTIONAL

Study Start Date

2015-08-31

Study Completion Date

2015-11-30

Brief Summary

Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.

A randomized controlled and endoscopist-blinded study which compares the efficacy of liquid simethicone (100mg) in 5 mls water, versus placebo ( 5mls of water), as premedication (given at least 30 minutes) before gastroscopy towards improvement of the total mucosal visibility score.

Detailed Description

Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.

Excessive bubbles or foam during gastroscopy is a common problem which can cause significant hindrance to an optimal evaluation of the gastric mucosa, prolong the procedure time, and contribute to poor patient tolerance during the scope.

Simethicone, with or without N-acetylcysteine, has been extensively evaluated to improve mucosal visibility. However, the volume of simethicone preparation and the timing of ingesting this solution before gastroscope varied significantly across different studies. In general, it appeared that a larger volume of simethicone solution, given earlier before the gastroscopy, may yield better results. However, allowing a patient to ingest a large volume of liquid before a gastroscopy under sedation brings forth the risk of aspiration. A recent Taiwanese study published in 2014 \[1\] showed that the subgroup with 100mg of simethicone in just 5ml of water, did achieve a good total mucosal visibility score, if the solution was ingested more than 30 minutes before the gastroscope. This may be because a longer time allows the simethicone to coat more of the mucosa. However, this study did not compare this preparation against a placebo.

In Changi General Hospital, many gastroscopies are done daily with no premedication. Also, there is no protocol for premedication before gastroscopes. This study hopes to prove that a low volume of simethicone solution, given at an ample time (more than 30 minutes) before the scope, can significantly improve overall endoscopy performance compared to no premedication at all.

Conditions

See the medical conditions and disease areas that this research is targeting or investigating.

Lesion of Stomach

Study Design

Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.

Allocation Method

RANDOMIZED

Intervention Model

PARALLEL

Blinding Strategy

SINGLE

Investigators

Study Groups

Review each arm or cohort in the study, along with the interventions and objectives associated with them.

Simethicone premedication

Liquid simethicone (1ml volume) in 5mls of water

Group Type EXPERIMENTAL

Simethicone

Intervention Type DRUG

100mg of liquid simethicone is put into 5mls of water and given at least 30 minutes before the gastroscopy.

Placebo

Just 5 mls of water

Group Type PLACEBO_COMPARATOR

Water

Intervention Type OTHER

5mls of water is given at least 30 minutes before the gastroscopy.

Interventions

Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.

Simethicone

100mg of liquid simethicone is put into 5mls of water and given at least 30 minutes before the gastroscopy.

Intervention Type DRUG

Water

5mls of water is given at least 30 minutes before the gastroscopy.

Intervention Type OTHER

Eligibility Criteria

Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.

Inclusion Criteria

* Planned for an elective diagnostic gastroscopy by the attending gastroenterologist
* Age of at least 21 years old
* Mentally competent and able to provide informed consent

Exclusion Criteria

* Category A patients (incarcerated prisoners)
* adults who are unable to give their own informed consent due to lack of mental capacity
* suspected gastrointestinal bleeding
* suspected impacted foreign material
* suspected gastric outlet obstruction
* suspected esophageal obstruction
* history of dysphagia
* known hypersensitivity to simethicone
* previous gastrectomy
Minimum Eligible Age

21 Years

Eligible Sex

ALL

Accepts Healthy Volunteers

No

Sponsors

Meet the organizations funding or collaborating on the study and learn about their roles.

Changi General Hospital

OTHER

Sponsor Role lead

Responsible Party

Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.

Responsibility Role SPONSOR

Locations

Explore where the study is taking place and check the recruitment status at each participating site.

Changi General Hospital

Singapore, , Singapore

Site Status

Countries

Review the countries where the study has at least one active or historical site.

Singapore

Other Identifiers

Review additional registry numbers or institutional identifiers associated with this trial.

CGH-QIPSMJ

Identifier Type: -

Identifier Source: org_study_id

More Related Trials

Additional clinical trials that may be relevant based on similarity analysis.

Pronase Granules in Gastric Cleaning
NCT05249933 UNKNOWN PHASE2/PHASE3
Gastric Ultrasound Versus Gastroscopic Aspiration
NCT07292935 NOT_YET_RECRUITING NA